Healthcare & Life Sciences
Healthcare Industry Translation Services Professional Medical, Precise Translation
For multinational pharmaceuticals, medical device manufacturers, CROs, and regulatory affairs teams. We deliver clinical study protocols, Instructions for Use (IFU), pharmacopoeia summaries, and regulatory dossiers compliant with FDA, EU MDR, and NMPA.
- PSB Reg. No. 3101150909750
- TAC Institutional Member
- ISO 17100 Certified Quality
- Strict Enterprise NDA
Key Industry Scenarios & Solutions
Comprehensive multilingual workflows for clinical research, medical device registration, and global pharmaceutical distribution.
Clinical Trials & Ethics Review
Clinical trial protocols, Informed Consent Forms (ICFs), Investigator's Brochures (IBs), and SAE reporting with uncompromising rigor.
Medical Device IFU & SaMD UI
Instructions for Use (IFUs), IVD reagent inserts, SaMD medical software UI strings, and patient safety alerts.
Regulatory Dossiers (eCTD & CE MDR)
Technical dossiers, Clinical Evaluation Reports (CERs), and biocompatibility studies compliant with EU MDR and FDA 21 CFR.
Package Inserts & Labels (SmPC / PIL)
Summary of Product Characteristics (SmPC), Patient Information Leaflets (PIL), packaging labels, and pharmacopoeia compliance.
Project Preparation
The following information helps align regulatory frameworks and match specialized medical reviewers.
Source Files
Provide clinical protocols, regulatory dossiers, medical device IFUs, or patient leaflets (Word, InDesign, PDF, XML).
Target Languages & Markets
Specify target submission countries, languages, and regulatory frameworks (FDA, EU MDR, NMPA, PMDA).
Purpose & Audience
Clarify submission context (health authority review, clinical trials, patient signing, device packaging).
Terminology & References
Submit legacy glossaries, MedDRA/WHO-ART coding rules, or previous registration archives.
Format & Timeline
Clarify if back-translation, ethics certificates, or expedited milestone turnarounds are required.
Industry Translation & Quality Workflow
Enforcing closed-loop workflows from terminology extraction and SME translation to layout alignment.
Scope & Terminology Extraction
Analyze document structures, drawing layers, and extract vertical domain terms into glossaries.
Domain Expert Translation
Match specialized translators with healthcare, IT, legal, or engineering backgrounds.
Dual Review & Numeric QA
Cross-verification of technical tolerances, safety alerts, and regulatory references.
Layout Inspection & Callout Sync
Preserving document hierarchy, callout references, and structural alignment per source conditions.
Handover & TM Archival
Deliver final files, QA audit logs, and archive confirmed termbases into customer TM.
Deliverables
The following deliverables are tailored per agreed project scope.
Deliverables
- Regulatory-compliant final translated documents (FDA / EU MDR / NMPA)
- Back-translation and clinician reconciliation reports
- Signed Certificate of Medical Translation Accuracy
- MedDRA and pharmacopoeia aligned medical glossaries
Prerequisites & Scope Notes
- Regulatory Scope: Translation certifies language fidelity; clinical study design remains sponsor responsibility
- Layman's Language: ICFs require balancing medical precision with 6th-8th grade reading comprehension
- eCTD Specifications: Granular PDF bookmarking and cross-linking specifications must be agreed
- IRB Submission Windows: Expedited reviewer assignments available for impending IRB deadlines
Medical Device IFU Translation Sample
Demonstrating cardiovascular stent IFU contraindications, parameters, and MedDRA terminology standards.
"CONTRAINDICATION: The drug-eluting coronary stent system is contraindicated in patients with known hypersensitivity to sirolimus or bioabsorbable polymer coatings, or with active bleeding diathesis."
"禁忌症：本药物洗脱冠状动脉支架系统禁用于对西罗莫司或生物可吸收聚合物涂层存在已知过敏史，或伴有活动性出血倾向的患者。"
| Source Medical Term | Regulatory Target Term | Standard & Class |
|---|---|---|
| Drug-Eluting Coronary Stent System | 药物洗脱冠状动脉支架系统 | NMPA Standard Device Nomenclature |
| Sirolimus | 西罗莫司 | Official Pharmacopoeia Drug Name |
| Active Bleeding Diathesis | 活动性出血倾向 | MedDRA Standard Symptom Nomenclature |
Cardiovascular Drug-Eluting Stent System IFU
Industry: Healthcare & Life Sciences · Standard: EU MDR 2017/745 & FDA 21 CFR
Official Device Nomenclature
Strictly aligned with official medical device classification guidance.
Zero Tolerance for Ambiguity
Zero tolerance for ambiguity across contraindications and adverse events.
Clinician Specialist Review
Second-pass review by medical practitioners and regulatory affairs specialists.
Related resources
Explore related services, vertical solutions and client case studies.
Related services
- Certified TranslationCertified translations for study abroad, immigration, visas, corporate registration and cross-border litigation—with translator statements, compliant layouts and company seals, plus rush lanes and pre-submission checklists.
- Financial, Legal & Corporate Document TranslationMission-critical translation for Big 4 audit reports, listed annual reports, IPO prospectuses, and cross-border commercial pacts. Enforced by CPA / financial dual-review, 100% financial cross-footing verification, and 24/7 financial printing shifts to eliminate AI hallucination and zero-omission risks in capital markets.
Related industry solutions
- Medical device translationMedtech registration, IFU, labeling and clinical docs—medical linguists plus review for MDR/FDA/NMPA compliance.
- IFU translationMedical device IFU translation with strict warning, illustration and layout alignment for FDA/MDR filings.
- FDA translationFDA 510(k), PMA, Q-sub and labeling/IFU translation aligned with US FDA formats and terminology.
Case studies
- Medical Device Documentation TranslationFull product documentation translation for an international medical device company, including technical specifications, user manuals, and safety guides. Delivered translated specs, manuals, and safety guides to support regulatory certification
- Class II Device IFU Translation for FDA 510(k)Translated IFU, labels and packaging copy for a Class II device US export aligned with 510(k) timeline. FDA consultant confirmed warning and UDI language meets 21 CFR expectations
Specialized Terminology Vault (TermBase) Sample & Reference
Strict subject-matter expert vetting and real-time TM locking guarantee precise technical accuracy.
| Source Term / Specification | Standardized Target Translation | Domain Context & Standards | 状态 |
|---|---|---|---|
| 伴随诊断试剂盒 (CDx) | Companion Diagnostic Kit (CDx) | FDA 21 CFR / NMPA IVD | 🔒 TermBase Locked |
| 510(k) 实质等同性判定论证 | 510(k) Substantial Equivalence Evaluation | FDA Center for CDRH Guidance | 🔒 TermBase Locked |
| 严重不良事件 (SAE) 因果归因 | Serious Adverse Event Causality Attribution | ICH E2A / GCP Guideline | 🔒 TermBase Locked |
| 植入物生物相容性细胞毒性测试 | Cytotoxicity & Biocompatibility Testing | ISO 10993-5 / MDR Annex I | 🔒 TermBase Locked |
Frequently asked questions
Common questions on pricing, turnaround, confidentiality and file formats—contact us for anything else.
Ready to Start Your Project?
Submit your requirements and files. Our consultant will provide a transparent quote and timeline within 24 hours.
What linguist profile do you use for Healthcare Industry Translation Services?
Are you familiar with regulatory and standard documentation?
How do you maintain content over time?
How much does Healthcare Industry Translation Services cost?
What factors affect translation pricing?
How long does translation take?
Ready to Start Your Project?
Submit your requirements and files. Our consultant will provide a transparent quote and timeline within 24 hours.
Discuss Your Healthcare Industry Translation Services Project
Submit technical drawings or draft chapters for a professional feasibility assessment.
